alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 81, Number 32 (Thursday, February 18, 2016)]
[Notices]
[Pages 8191-8192]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-03312]


-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. EL16-17-000]


City of West Memphis, Arkansas; Notice of Filing

    Take notice that on February 10, 2016, the City of West Memphis, 
Arkansas submitted a supplement to its November 19, 2015 application 
for proposed rate for Reactive Supply and Voltage Control.
    Any person desiring to intervene or to protest this filing must 
file in accordance with Rules 211 and 214 of the Commission's Rules of 
Practice and Procedure (18 CFR 385.211, 385.214). Protests will be 
considered by the Commission in determining the appropriate action to 
be taken, but will not serve to make protestants parties to the 
proceeding. Any person wishing to become a party must file a notice of 
intervention or motion to intervene, as appropriate. Such notices, 
motions, or protests must be filed on or before the comment date. 
Anyone filing a motion to intervene or protest must serve a copy of 
that document on the Applicant and all the parties in this proceeding.
    The Commission encourages electronic submission of protests and 
interventions in lieu of paper using the ``eFiling'' link at http://www.ferc.gov. Persons unable to file electronically should submit an 
original and 5 copies of the protest or intervention to the Federal 
Energy Regulatory Commission, 888 First Street NE., Washington, DC 
20426.
    This filing is accessible on-line at http://www.ferc.gov, using the 
``eLibrary'' link and is available for electronic review in the 
Commission's Public Reference Room in Washington, DC. There is an 
``eSubscription'' link on the Web site that enables subscribers to 
receive email notification when a document is added to a subscribed 
docket(s). For assistance with any FERC Online service, please email 
<a href="/cdn-cgi/l/email-protection#e7a1a2b5a4a8898b8e8982b4929797889593a781829584c9808891"><span class="__cf_email__" data-cfemail="bdfbf8effef2d3d1d4d3d8eec8cdcdd2cfc9fddbd8cfde93dad2cb">[email protected]</span></a>, or call (866) 208-3676 (toll free). For 
TTY, call (202) 502-8659.

[[Page 8192]]

    Comment Date: 5:00 p.m. Eastern Time on February 17, 2016.

    Dated: February 10, 2016.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2016-03312 Filed 2-17-16; 8:45 am]
 BILLING CODE 6717-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

January 4, 2019

RE: Product Exclusion Request Number: USTR-2018-0025-2688

Primex Family of Companies:

The purpose of this letter is to inform you that the product exclusion request referenced 

above has been denied. As you are aware, USTR published a Federal Register notice (83 FR 

28710) on June 20, 2018, that announced the Trade Representative’s determination to impose an 

additional duty of 25 percent on certain products from China. On July 11, 2018, the Trade 

Representative published a Federal Register notice (83 FR 32181) which announced that a 

process had been established under which interested persons could request that products falling 

within a covered HTSUS subheading be excluded from the additional duties announced on June 

20. 

Your request was reviewed in accordance with the factors and procedures set forth in 

Section B(1) of the July 11 notice. Based on that review, and after careful consideration, your 

request was denied because the request failed to show that the imposition of additional duties on 

the particular product would cause severe economic harm to you or other U.S. interests.

Because USTR will grant exclusion requests on a product specific basis, you may still 

benefit from a product exclusion if a similar product is granted an exclusion. Products for which 

an exclusion has been granted will be periodically announced on the USTR website. Product 

exclusions will become legally effective once published in the Federal Register. 

Sincerely,

Stephen P. Vaughn
<PAGE>




                                                                    Exhibit 23.1


            CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM




We hereby consent to the incorporation by reference in the previously filed
Registration Statements of Aethlon Medical, Inc. on Form S-8 (File No.
333-127911 and 333-114017 and 333-49896) of our report, dated July 12, 2007
appearing in this Annual Report on Form 10-KSB of Aethlon Medical, Inc. for the
year ended March 31, 2007.


                          /s/ Squar, Milner, Peterson, Miranda & Williamson, LLP
                          ------------------------------------------------------
                          Squar, Milner, Peterson, Miranda & Williamson, LLP


Newport Beach, California
July, 12, 2007
[Federal Register Volume 60, Number 49 (Tuesday, March 14, 1995)]
[Notices]
[Page 13720]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-6173]



[[Page 13720]]

DEPARTMENT OF ENERGY

[Docket No. RP95-137-002]


Northern Natural Gas Co.; Notice of Proposed Changes in FERC Gas 
Tariff

March 8, 1995.
    Take notice that on March 6, 1995, Northern Natural Gas Company 
(Northern), tendered for filing changes in its FERC Gas Tariff, Fifth 
Revised Volume No. 1.
    Northern states that the filing is being made in compliance with 
the February 23, 1995, Commission Order in the captioned Docket. That 
Order directed Northern; (1) to re-establish the direct bill amounts by 
shipper resulting from the buyout of the Pan Alberta Gas (U.S.) 
Exchange Agreement by removing the costs of the January 1996 payment 
which is yet to be made, and (2) to provide specific additional 
supporting information. Therefore Northern has filed the additional 
supporting information and a Second Substitute Third Revised Sheet No. 
68 and will commence billing effective March 1, 1995.
    Northern states that copies of this filing were served upon the 
company's customers and interested State Commissions.
    Any person desiring to protest said filing should file a protest 
with the Federal Energy Regulatory Commission, 825 North Capitol 
Street, NE., Washington, DC 20426, in accordance with Section 385.211 
of the Commission's Rules and Regulations. All such protests should be 
filed on or before March 15, 1995. All protests will be considered by 
the Commission in determining the appropriate proceeding, but will not 
serve to make protestant a party to the proceedings. Copies of this 
filing are on file with the Commission and are available for 
inspection.
Lois D. Cashell,
Secretary.
[FR Doc. 95-6173 Filed 3-13-95; 8:45 am]
BILLING CODE 6717-01-M
Exhibit 23.2





CONSENT OF ERNST & YOUNG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM





We consent to the incorporation by reference in the following Registration Statements:





(1)     Registration Statement (Form S-3 no. 333-36708) of PDL BioPharma, Inc.,


(2)     Registration Statement (Form S-3 No. 333-122760) of PDL BioPharma, Inc.,


(3)     Registration Statement (Form S-3 No. 333-123958) of PDL BioPharma, Inc.,


(4)     Registration Statement (Form S-3 No. 333-128644) of PDL BioPharma, Inc.,


(5)     Registration Statement (Form S-3ASR No. 333-174052) of PDL BioPharma, Inc.,


(6)    Registration Statement (Form S-3ASR No. 333-189536) of PDL BioPharma, Inc.,


|    |                                                                                                                                                         
|--- | --------------------------------------------------------------------------------------------------------------------------------------------------------
|(7) | Registration Statement (Form S-8 No. 333-87957) pertaining to the 1999 Stock Option Plan and 1999 Nonstatutory Stock Option Plan of PDL BioPharma, Inc.,

|    |                                                                                                                                                         
|--- | --------------------------------------------------------------------------------------------------------------------------------------------------------
|(8) | Registration Statement (Form S-8 No. 333-68314) pertaining to the 1999 Stock Option Plan and 1999 Nonstatutory Stock Option Plan of PDL BioPharma, Inc.,

|    |                                                                                                                               
|--- | ------------------------------------------------------------------------------------------------------------------------------
|(9) | Registration Statement (Form S-8 No. 333-104170) pertaining to the 1999 Nonstatutory Stock Option Plan of PDL BioPharma, Inc.,

|     |                                                                                                                          
|---- | -------------------------------------------------------------------------------------------------------------------------
|(10) | Registration Statement (Form S-8 No. 333-125906) pertaining to the 2005 Equity Incentive Plan of PDL BioPharma, Inc., and

(11)     Registration Statement (Form S-8 No. 333-145262) pertaining to the 2005 Equity Incentive Plan.





of our report dated March 3, 2014, with respect to the consolidated financial statements of PDL BioPharma, Inc., included in the Annual Report (Form 10-K) for the year ended December 31, 2014 originally filed on February 23, 2015.








/s/    ERNST & YOUNG LLP





Redwood City, California


March 11, 2015
Exhibit 31.2





Certification
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002



I, Gregory K. Chow, certify that:



1.I have reviewed this Amendment No. 3 to Annual Report on Form 10-K/A of Aptose Biosciences Inc.; and



2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material
fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading
with respect to the period covered by this report.





Date: April 22, 2019



| | /s/ Gregory K. Chow
        
        Name: Gregory K. Chow
        
        Title: Senior Vice President and Chief Financial Officer
| | ------------------------------------------------------------------------------------------------------------------------------------
SCPW-20-0000559

IN THE SUPREME COURT OF THE STATE OF HAWAI # I

BERNARD HOSEA MAHUIKI, JR., Petitioner,

vs.

STATE OF HAWAI # I, Respondent.

ORIGINAL PROCEEDING (CASE NO. 5FFC-18-0000137)

O RDER DENYING PETITION ( By: Recktenwald, C.J., Nakayama, and McKenna, JJ., and Circuit Judge Crabtree, assigned by reason of vacancy,

with Wilson, J., concurring)
Upon consideration of petitioner Bernard Hosea Mahuiki’s “Motion to Release Non-Violent Community Custody Prisoner from Custody with Special Release Terms and Conditions Amid the Coronavirus COVID-19 Bio-Terrorism Pandemic”, which was filed as a petition on September 11, 2020, the documents attached thereto and submitted in support thereof, and the record, it appears that petitioner fails to demonstrate that he is entitled to the requested extraordinary relief from this court. See Kema v. Gaddis, 91 Hawai # i 200, 204, 982 P.2d 334, 338 (1999) (a writ of mandamus is an extraordinary remedy that will not issue unless the petitioner demonstrates a clear and indisputable right to relief and a lack of alternative means to redress adequately the alleged wrong or obtain the requested action); Oili v. Chang, 54 Electronically Filed Supreme Court SCPW-20-0000559 30-SEP-2020 02:34 PMHaw. 411, 412, 557 P.2d 787, 788 (1976) (“[The supreme] court

will not exercise its original jurisdiction in habeas corpus proceedings when relief is available in a lower court and no special reason exists for invoking its jurisdiction.”). Accordingly,

IT IS HEREBY ORDERED that the petition is denied.
IT IS HEREBY FURTHER ORDERED that the clerk of the appellate court shall process the petition without payment of the filing fee.

DATED: Honolulu, Hawai # i, September 30, 2020. /s/ Mark E. Recktenwald /s/ Paula A. Nakayama /s/ Sabrina S. McKenna /s/ Jeffrey P. Crabtree

CONCURRENCE (By: Wilson, J.) For the reasons stated in my concurrence order in Sandry v. State, SCPW-20-0000405, filed on June 24, 2020, I

concur. /s/ Michael D. Wilson

2
<PAGE>


EXHIBIT 3.1

                            CERTIFICATE OF AMENDMENT

                                       OF

                      RESTATED CERTIFICATE OF INCORPORATION

                                       OF

                        GENEREX BIOTECHNOLOGY CORPORATION


         Generex Biotechnology Corporation, a corporation organized and existing
under and by virtue of the General Corporation Law of the State of Delaware,

         DOES HEREBY CERTIFY:

         FIRST: That the Board of Directors of said corporation, adopted a
resolution proposing and declaring advisable the following amendment to the
Restated Certificate of Incorporation of said corporation:

         RESOLVED, that the Restated Certificate of Incorporation of Generex
         Biotechnology Corporation be amended by changing Article IV thereof so
         that, as amended, said Article shall be and read as follows:

         "ARTICLE IV: The aggregate number of shares of all classes of stock
         that this Corporation shall have the authority to issue is 151,000,000
         shares, consisting of (a) 150,000,000 shares of common stock, par value
         $.001 per share, and (b) 1,000,000 shares of preferred stock, par value
         $.001 per share. The preferred stock may be issued in one or more
         series and may have preferences as to dividends and to liquidation of
         the Corporation. The Board of Directors of the Corporation shall
         establish the specific rights, preferences, voting privileges and
         restrictions of such preferred stock, or any series thereof."

         SECOND: That thereafter, pursuant to resolution of its Board of
Directors, a special meeting of the stockholders of said corporation was duly
called and held upon notice given in accordance with Section 222 of the General
Corporation Law of the State of Delaware, at which meeting the necessary number
of shares as required by statute were voted in favor of the amendment.

         THIRD: That the aforesaid amendment was duly adopted in accordance with
the applicable provisions of Sections 242 and 211(d) of the General Corporation
Law of the State of Delaware.

         IN WITNESS WHEREOF, said Generex Biotechnology Corporation has caused
this Certificate to be signed by Mark Fletcher, its Executive Vice President and
General Counsel on December , 2003.


                                GENEREX BIOTECHNOLOGY CORPORATION


                                By:  /s/ Mark Fletcher
                                   -------------------------------------------
                                     Mark Fletcher, Executive Vice President
                                     and General Counsel
#### STATE v. RANSOM MURPHY.

(Filed 29 October, 1952.)

Appeal by defendant from *Burney, J.,*at August Term, 1952, of SAMPSON.

Criminal prosecution upon warrant issued out of County Eecorder’s Court, tried in Superior Court of Sampson County, on appeal thereto from judgment of the Eeeorder’s Court charging, as limited by the trial judge, that defendant violated prohibition laws in manner therein stated.

Yerdict: “Guilty of possession for the purpose of sale and of operating a public nuisance.”

Judgment: Confinement in the common jail, etc.

On appeal therefrom to the Supreme Court at Spring Term, 1952, no error was found. See 235 N.C. 503, 70 S.E. 2d 498.

Thereafter at the next succeeding term, August Term, 1952, of Superior Court of Sampson County, N. C., defendant filed in writing a motion for new trial on account of newly discovered evidence, — supporting same by certain affidavits.

The presiding judge, after considering said written motion and affidavits filed therewith, and on examination of the record of the case on appeal to the Supreme Court, as aforesaid, denied the motion in his discretion.

From order in accordance therewith defendant appeals to Supreme Court, and assigns error.

*Attorney-General McMullan and Assistant Attorney-General Bruton for the State.*

*David J. Turlington, Jr., for defendant, appellant.*

Per Curiam.

Appeal to the Supreme Court does not lie from a discretionary determination of an application for a new trial on the ground of newly discovered evidence. Hence, under authority of case of *S. v. Bryant, ante,*379, opinion this day handed down, the appeal in the present case is

Dismissed.
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

February 4, 2019

RE: Product Exclusion Request Number: USTR-2018-0025-3591

Stanley Electric Co, Ltd:

The purpose of this letter is to inform you that the product exclusion request referenced 

above has been denied. As you are aware, USTR published a Federal Register notice (83 FR 

28710) on June 20, 2018, that announced the Trade Representative’s determination to impose an 

additional duty of 25 percent on certain products from China. On July 11, 2018, the Trade 

Representative published a Federal Register notice (83 FR 32181) which announced that a 

process had been established under which interested persons could request that products falling 

within a covered HTSUS subheading be excluded from the additional duties announced on June 

20.

Your request was reviewed in accordance with the factors and procedures set forth in 

Section B(1) of the July 11 notice. Based on that review, and after careful consideration, your 

request was denied because the request failed to show that the imposition of additional duties on 

the particular product would cause severe economic harm to you or other U.S. interests.

Because USTR will grant exclusion requests on a product specific basis, you may still 

benefit from a product exclusion if a similar product is granted an exclusion. Products for which 

an exclusion has been granted will be periodically announced on the USTR website. Product 

exclusions will become legally effective once published in the Federal Register. 

Sincerely,

Stephen P. Vaughn

General Counsel
Michigan Supreme Court

Lansing, Michigan

Robert P. Young, Jr.

, Chief Justice

Stephen J. Markman

Brian K. Zahra

Bridget M. McCormack

David F. Viviano

Richard H. Bernstein

Joan L. Larsen,

Justices

I, Larry S. Royster , Clerk of the Michigan Supreme Court, certify that the

foregoing is a true and complete copy of the order entered at the direction of the Court.

October 5, 2016

a0928 

# Order

Clerk October 5, 2016

152841

PEOPLE OF THE STATE OF MICHIGAN,

Plaintiff

- Appellee,

v SC: 152841

COA: 322179

Genesee CC: 13

- 033536

- FC

DEON JEFFERSON JOHNSON,

Defendant

- Appellant.

_________________________________________/

On order of the Court, the application for leave to appeal the October 22, 2015

judgment of the Court of Appeals is considered and, it appe aring to this Court that the

case of People v Comer (Docket No. 152713) is pending on appeal before this Court and

that the decision in that case may resolve an issue raised in the present application for

leave to appeal, we ORDER that the application be h eld in ABEYANCE pending the

decision in that case.
Exhibit 32.2

CERTIFICATION OF CHIEF
FINANCIAL OFFICER 
PURSUANT TO 
18 U.S.C. SECTION 1350, 
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I,
Kevin C. Eichler, certify, to the best of my knowledge, that based upon a review of the
Quarterly Report on Form 10-Q of MIPS Technologies, Inc. for the three months ended
December 31, 2004 (theForm 10-Q), the Form 10-Q fully complies with the
requirements of Section 13(a) of the Securities Exchange Act of 1934, as amended, and that
information contained in the Form 10-Q fairly presents, in all material respects, the
financial condition and results of operations of MIPS Technologies, Inc. for the three
month period covered by the Form 10-Q.

|                         |                                           
|------------------------ | ------------------------------------------
|                         |                                           
|                         |                                           
|                        
|Dated:  February 7, 2005 | By:     /s/ KEVIN C. EICHLER              
|                         | Kevin C. Eichler                          
|                         | Vice President and Chief Financial Officer
|                         | MIPS Technologies, Inc.                   

A signed original of this written
statement required by Section 906 has been provided by MIPS Technologies and will be
retained by it and furnished to the Securities Exchange Commission or its staff upon
request.

1

---
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

December 28, 2018

RE: Product Exclusion Request Number: USTR-2018-0025-3158

NSK Steering Systems America:

I am pleased to notify you that the United States Trade Representative has determined to 

grant the above-referenced exclusion request submitted pursuant to the notice published at 83 FR 

32181 (‘July 11 notice’). The exclusion determination is set out in a formal notice which has 

been submitted to Office of the Federal Register for publication (‘the exclusion notice’). A prepublication version of the exclusion notice has been posted on the USTR website, at 

https://ustr.gov/sites/default/files/enforcement/301Investigations/12.21.18_Notice_of_Product_E

xclusions.pdf.

The scope of the exclusion is governed by the formal HTSUS language in the annex to 

the product exclusion notice, and not by the product descriptions set out in any particular request 

for exclusion. An exclusion in response to your request has been granted by excluding from the

additional tariffs the 10-digit HTSUS subheading under which your request was filed. 

In accordance with the July 11 notice, the exclusion applies as of the July 6, 2018 

effective date of the tariff action, and will extend for one year after the exclusion notice is 

published in the Federal Register. As stated in the exclusion notice, U.S. Customs and Border 

Protection will issue additional instructions on entry guidance and implementation.

Sincerely,

Stephen P. Vaughn

General Counsel